. Author manuscript; available in PMC: 2019 Mar 8.

Published in final edited form as: Mol Cell. 2018 Oct 4;72(2):222–238.e11. doi: 10.1016/j.molcel.2018.08.047

Table 1.

Genomic Features of BrITL sites in human breast cancer cells

	Genic		Inter- genic	H3 K4^me3	H3 K27^ac	H3 K36^me3	TTRs	CTCF	CFS
	Intron	Exon	Inter- genic	H3 K4^me3	H3 K27^ac	H3 K36^me3	TTRs	CTCF	CFS
% of BrITL sites overlapping (sites observed)	37.7%		62.3%	9.0% (15)	3.0% (5)	0% (0)	15.6% (26)	6.0% (10)	21.0% (35)
% of BrITL sites overlapping (sites observed)	26.3%	11.3%	62.3%	9.0% (15)	3.0% (5)	0% (0)	15.6% (26)	6.0% (10)	21.0% (35)
% coverage of human genome (sites expected)	53.3%^*		46.7%^*	0.34% (1) ^**	0.78% (1) ^**	1.4% (2) ^**	11.6% (19) ^*	0.36% (1) ^**	14.9% (25) ^***
% coverage of human genome (sites expected)	49.4^*	3.9%^*	46.7%^*	0.34% (1) ^**	0.78% (1) ^**	1.4% (2) ^**	11.6% (19) ^*	0.36% (1) ^**	14.9% (25) ^***
p value	-	-		<10⁻⁴	0.11	1.0	0.07	0.08	0.02

^**

ENCODE database (MCF7),

^***

Fungtammasan et al., 2012